Fundraising Cognitive Disorder Videogame Maker Akili Has Big Pharma Buy-In
This article was originally published in Scrip
What if a video game could treat a player's cognitive disorder? It may sound like a sci-fi fantasy, but a company developing such a platform has secured the backing of Shire and Jazz Venture Partners, entered into a partnership with Pfizer and has recently raised $30.5m in equity investments.
You may also be interested in...
Akili Interactive Labs Inc., a digital medicine company, has secured an additional $11.9m funding via series B financing with backing from Merck KGaA and Amgen Inc.
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.